Epilepsy
Conditions
Interventions
Lacoxamide oral treatment group:NA
Sponsors
Shengjing Hospital of China Medical University
Eligibility
Sex/Gender
All
Age
4 Years to 12 Years
Inclusion criteria
Inclusion criteria: (1) Age = 6 years and = 11 years; (2) Children initially diagnosed with focal epilepsy combined with ADHD, with the diagnosis of focal epilepsy meeting the 2017 ILAE epilepsy diagnosis and classification criteria, and the diagnosis of ADHD meeting the DSM-5 diagnostic criteria; (3) Previously, there was no medication treatment for epilepsy and ADHD; (4) The parents of the child are unable to conduct Behaviour therapy for ADHD of the child due to various reasons, or have conducted Behaviour therapy but have no effect.
Exclusion criteria
Exclusion criteria: (1) Age11 years old; (2) Before diagnosing focal epilepsy with ADHD, there is developmental delay (including intellectual impairment/generalized developmental delay, autism spectrum disorders, language development disorders, motor development disorders, etc.); (3) Suffering from serious diseases of other systems (such as liver and kidney dysfunction, severe heart disease, etc.); (4) Suffer from other diseases requiring long-term use of central nervous system stimulants or sedation (such as narcolepsy, Tic disorder, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SNAP-IV score;Epilepsy control situation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Seizure free rate;ADHD control situation;Developmental and cognitive abilities; | — |
Countries
China
Contacts
Public ContactLiu Xueyan
Shengjing Hospital of China Medical University
Outcome results
None listed